Physician profile
Jason E Morris
NPI 1306856018
$1,853.12
in general payments reported to CMS, 2019-2025
14 companies · $27.53 in 2025
The $27.53 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $350 · 2020: $260 · 2021: $159 · 2022: $431 · 2023: $463 · 2024: $163 · 2025: $27.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $653.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $653.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,007.77 | 2021-2024 | Puraply |
| Horizon Therapeutics Plc | $376.64 | 2019-2022 | |
| Kerecis Limited | $142.67 | 2019-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Zyla Life Sciences, INC. | $72.35 | 2019 | |
| Aroa Biosurgery Incorporated | $52.31 | 2020 | |
| Smith+Nephew, INC. | $47.39 | 2019-2025 | Collagenase Santyl |
| Musculoskeletal Transplant Foundation INC. | $27.47 | 2019 | |
| Triad Life Sciences INC. | $24.12 | 2022 | |
| Zimmer Biomet Holdings, INC. | $21.11 | 2020 | |
| Melinta Therapeutics, LLC | $20.08 | 2020 | |
| Nevro Corp. | $16.43 | 2023 | Senza |
| Sandoz INC. | $15.45 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $15.33 | 2019 | |
| Reprise Biomedical, INC. | $14.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.